$PRVB 13 business days left until the end of Q3 and the filing of the clinical module. Then the CMC will be filed in October and the FDA will take up to two months to set a PDUFA date. Priority review means approval should be in June or July. Sales should begin in August or September. Hopefully by then at risk for T1D screening will be a lot more common.